4
MARKET OVERVIEW
AI-driven innovations unlock growth in protein-based drug development despite high costs and technical barriers.
42
4.2.1.1
INCREASING EMPHASIS ON STRUCTURE-BASED DRUG DISCOVERY AND DEVELOPMENT
4.2.1.2
RISING DEMAND FOR PROTEIN-BASED DRUG DEVELOPMENT
4.2.1.3
INCREASING DEMAND FOR THERAPEUTIC PROTEINS
4.2.1.4
TECHNOLOGICAL ADVANCEMENTS IN CRYSTALLIZATION METHODS
4.2.2.1
HIGH TECHNICAL COMPLEXITY AND LOW SUCCESS RATES IN PROTEIN CRYSTALLIZATION
4.2.2.2
EXPOSURE TO IONIZING RADIATION AND CONTRAST-RELATED CONCERNS AMONG VULNERABLE POPULATIONS
4.2.2.3
NEED FOR HIGH COSTS, TECHNICAL EXPERTISE, AND ADVANCED INFRASTRUCTURE FOR COMMERCIALIZATION
4.2.3.1
INTEGRATION OF AI-ENABLED INNOVATIONS
4.2.3.2
COLLABORATION BETWEEN ACADEMIA AND INDUSTRY
4.2.3.3
HIGH INVESTMENT AND FUNDING IN STRUCTURAL BIOLOGY, BIOPHARMACEUTICALS, AND ADVANCED DRUG DEVELOPMENT
4.2.4.1
REPRODUCIBILITY ISSUES IN PROTEIN CRYSTALLIZATION
4.2.4.2
SCALABILITY CONCERNS IN RECOMBINANT PROTEIN PRODUCTION
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER1/2/3 PLAYERS
5
INDUSTRY TRENDS
Navigate evolving industry dynamics with strategic insights from comprehensive supply chain and pricing analyses.
51
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
BARGAINING POWER OF BUYERS
5.1.2
BARGAINING POWER OF SUPPLIERS
5.1.3
THREAT OF NEW ENTRANTS
5.1.4
THREAT OF SUBSTITUTES
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMIC OUTLOOK
5.2.1
GDP TRENDS & FORECAST
5.2.2
TRENDS IN GLOBAL ENVIRONMENTAL INDUSTRY
5.2.3
TRENDS IN GLOBAL HEALTHCARE INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.3.1
PROMINENT COMPANIES
5.3.2
SMALL & MEDIUM-SIZED ENTERPRISES
5.4.1
RESEARCH & DEVELOPMENT
5.4.3
DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
5.6.1
AVERAGE SELLING PRICE OF PROTEINS & PROTEIN CRYSTALS, BY PRODUCT, 2024
5.6.2
AVERAGE SELLING PRICE TREND OF PROTEINS & PROTEIN CRYSTALS, BY REGION, 2022–2024
5.7.1
IMPORT DATA FOR HS CODE 3507, 2021–2024
5.7.2
EXPORT DATA FOR HS CODE 3507, 2021–2024
5.7.3
TRADE ANALYSIS FOR HS CODE 293719
5.8
KEY CONFERENCES & EVENTS, 2025–2026
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.10
INVESTMENT & FUNDING SCENARIO
5.11.1
COMPUTATIONAL DESIGN OF HIGH-AFFINITY MINIBINDER PROTEINS FOR THERAPEUTIC TARGETS
5.12
IMPACT OF 2025 US TARIFF ON PROTEINS & PROTEIN CRYSTALS MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.4
IMPACT ON COUNTRY/REGION
5.12.5
IMPACT ON END-USE INDUSTRIES
6
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS
Harness emerging tech and AI to revolutionize the proteins market and overcome adoption barriers.
71
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
CRYO-CRYSTALLIZATION
6.1.2
X-RAY FREE-ELECTRON LASERS (XFELS)
6.1.3
COMPUTATIONAL PROTEIN DESIGN TOOLS
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
MICROFLUIDICS AND LAB-ON-A-CHIP (LOC) TECHNOLOGIES
6.2.2
NUCLEAR MAGNETIC RESONANCE (NMR) SPECTROSCOPY
6.4
IMPACT OF AI/GEN AI ON PROTEINS & PROTEIN CRYSTALS MARKET
6.4.1
TOP USE CASES AND MARKET POTENTIAL
6.4.2
BEST PRACTICES IN PROTEINS & PROTEIN CRYSTALS MARKET
6.4.4
INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
6.4.5
CLIENT’S READINESS TO ADOPT GEN AI IN PROTEINS & PROTEIN CRYSTALS MARKET
6.5
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
6.6.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.8
CERTIFICATIONS, LABELLING, AND ECO-STANDARDS
6.8.1
CERTIFICATIONS & GOOD MANUFACTURING/QUALITY STANDARDS
6.8.2
LABELLING & TRACEABILITY
6.8.3
ECO-STANDARDS/ENVIRONMENTAL/SUSTAINABILITY CERTIFICATION
6.9
CUSTOMER LANDSCAPE & BUYER BEHAVIOUR
6.9.1
DECISION-MAKING PROCESS
6.10
KEY STAKEHOLDERS & BUYING CRITERIA
6.10.1
KEY STAKEHOLDERS IN BUYING PROCESS
6.10.2
KEY BUYING CRITERIA
6.11
ADOPTION BARRIERS AND INTERNAL CHALLENGES
6.12
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
7
PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Billion | 22 Data Tables
86
7.2.1.1
FOCUS ON GREEN MANUFACTURING AND SUSTAINABLE SOLUTIONS TO AID ADOPTION
7.2.2.1
EXPANSION OF FOOD-BASED TECHNOLOGIES TO PROPEL MARKET GROWTH
7.3.1
MONOCLONAL ANTIBODIES
7.3.1.1
ADVANCING DISEASE TARGETING AND TREATMENT THROUGH MONOCLONAL ANTIBODY TECHNOLOGIES TO SPUR ADOPTION
7.3.2.1
STRENGTHENING INVESTMENT SCENARIO FOR INSULIN DEVELOPMENT TO FUEL MARKET GROWTH
7.3.3.1
INTRODUCTION OF NEW DRUGS AND THERAPIES FOR HORMONAL DISEASES TO PROPEL SEGMENT GROWTH
7.3.4
COAGULATION FACTORS
7.3.4.1
ENHANCED HEMOSTASIS THERAPIES THROUGH ADVANCED COAGULATION PROTEIN TECHNOLOGIES TO AUGMENT MARKET GROWTH
7.4.1.1
RESEARCH PROTEINS TO EMPOWER DRUG DISCOVERY AND MOLECULAR RESEARCH WITH AI INTEGRATION
7.4.2
STRUCTURAL PROTEINS
7.4.2.1
ADVANCEMENTS IN STRUCTURAL PROTEIN THROUGH COLLAGEN AND CONNECTIVE TISSUE INSIGHTS TO FUEL MARKET GROWTH
7.5.1
INDUSTRIAL PROTEINS
7.5.1.1
INDUSTRIAL PROTEINS TO OPTIMIZE INDUSTRIAL PROCESSES THROUGH ADVANCED PROTEIN TECHNOLOGIES
7.5.2
NUTRITIONAL PROTEINS
7.5.2.1
NUTRITIONAL PROTEINS TO ENABLE EVIDENCE-BASED, DISEASE-SPECIFIC NUTRITION FOR COMPLEMENTING PHARMACEUTICAL THERAPIES
7.5.3
ANALYTICAL PROTEINS
7.5.3.1
ANALYTICAL PROTEINS TO SUPPORT QUALITY CONTROL AND SCIENTIFIC DISCOVERY
7.5.4
COSMECEUTICAL PROTEINS
7.5.4.1
FOCUS ON INNOVATIVE PERSONAL CARE PRODUCTS TO SUPPORT SEGMENT GROWTH
7.5.5
FUNTIONAL FOOD PROTEINS
7.5.5.1
FUNCTIONAL FOODS & BEVERAGES WITH ADVANCED PROTEINS TO IMPROVE DIGESTIBILITY OF NUTRITIONAL PROFILE
8
PROTEINS & PROTEIN CRYSTALS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Billion | 9 Data Tables
105
8.2.1
ADVANCEMENTS IN PROTEIN ENGINEERING, STRUCTURAL BIOLOGY, AND HIGH-THROUGHPUT CRYSTALLIZATION TO SPUR MARKET
8.3.1
DEVELOPMENT OF ADVANCED REGENERATIVE MEDICINE THROUGH PROTEIN-BASED TISSUE ENGINEERING TO AID MARKET GROWTH
8.4
AGRICULTURE & ANIMAL NUTRITION
8.4.1
FOCUS ON BETTER AGRICULTURAL PRODUCTIVITY AND ANIMAL HEALTH THROUGH PROTEIN-BASED SOLUTIONS TO DRIVE MARKET
8.5
INDUSTRIAL PROCESSING
8.5.1
GROWING DEMAND FOR HIGH-PERFORMANCE AND ECO-FRIENDLY PRODUCTS TO DRIVE MARKET GROWTH
8.6
BIOENERGY & ENVIRONMENTAL
8.6.1
GROWING DEMAND FOR SUSTAINABLE ENERGY AND ECO-FRIENDLY SOLUTIONS TO BOOST MARKET GROWTH
8.7
COMECEUTICALS & NUTRACEUTICALS
8.7.1
ADVANCEMENTS IN PROTEIN-BASED NUTRACEUTICALS TO ENHANCE DIGESTIBILITY AND NUTRIENT DELIVERY
9
PROTEINS & PROTEIN CRYSTALS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Billion | 17 Data Tables
114
9.2.1.1
INCREASED INTERNAL BIOLOGICS DISCOVERY AND PROCESS-DEVELOPMENT ACTIVITY TO AUGMENT MARKET GROWTH
9.2.2
FORMULATION/MANUFACTURING
9.2.2.1
ADVANCING PROTEIN THERAPEUTICS THROUGH OPTIMIZED FORMULATION AND MANUFACTURING TO PROPEL SEGMENT GROWTH
9.2.3
STORAGE/INVENTORY MANAGEMENT
9.2.3.1
OPTIMAL STORAGE/INVENTORY MANAGEMENT TO OPTIMIZE SUPPLY, REDUCE WASTE, AND PREVENT STOCKOUTS
9.3
BIOTECHNOLOGY INDUSTRY
9.3.1.1
GROWTH OF PRECISION/PERSONALIZED MEDICINES AND ADVANCED THERAPEUTICS TO AID SEGMENT GROWTH
9.3.2
FORMULATION/MANUFACTURING
9.3.2.1
EXPANSION OF MANUFACTURING FACILITIES IN BIOTECHNOLOGY INDUSTRY LEADING TO SUPPORT MARKET GROWTH
9.3.3
STORAGE/INVENTORY MANAGEMENT
9.3.3.1
OPTIMIZING STORAGE AND INVENTORY MANAGEMENT FOR PROTEINS AND PROTEIN CRYSTALS TO ENHANCE SAFETY, QUALITY, AND ACCESSIBILITY
9.4
RESEARCH, ACADEMIA, AND CROS
9.4.1
DRUG DEVELOPMENT & DISCOVERY
9.4.1.1
FOCUS ON ACCELERATING ADVANCEMENTS PROTEIN & PROTEIN CRYSTAL APPLICATIONS TO FUEL SEGMENT GROWTH
9.4.2
LIFE SCIENCE RESEARCH
9.4.2.1
EXPANDING SCOPE OF RESEARCH FOR FORMULATING TARGETED TREATMENT STRATEGIES TO BOOST MARKET
9.5
FOOD & BEVERAGE INDUSTRY
9.5.1
INCREASING DEMAND FOR HIGH PROTEIN DIETS, NUTRITIONAL SUPPLEMENTS, AND FUNCTIONAL FOODS TO AID MARKET GROWTH
10
PROTEINS & PROTEIN CRYSTALS MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 137 Data Tables.
128
10.2.1.1
US TO DOMINATE NORTH AMERICAN PROTEINS & PROTEIN CRYSTALS MARKET DURING STUDY PERIOD
10.2.2.1
INNOVATIONS IN PROTEIN AI TO DRIVE ADVANCED PROTEIN DESIGN AND STRUCTURE PREDICTION
10.3.1.1
FAVORABLE HEALTHCARE POLICIES AND REGULATORY LANDSCAPE TO DRIVE MARKET
10.3.2.1
FAVORABLE REGULATORY SCENARIO FOR PROTEIN & PROTEIN CRYSTAL DEVELOPMENT TO SUPPORT MARKET GROWTH
10.3.3.1
INCREASED HEALTHCARE FUNDING BY GOVERNMENT BODIES TO AID MARKET GROWTH
10.3.4.1
INCREASED AVAILABILITY OF REIMBURSEMENT COVERAGE FOR PROTEINS AND PROTEIN CRYSTALS TO AUGMENT MARKET GROWTH
10.3.5.1
ONGOING RESEARCH LINKING CRYSTALLOGRAPHY TO DISEASE MECHANISMS AND INFRASTRUCTURE DEVELOPMENT TO AID MARKET GROWTH
10.4.1.1
EMPHASIS ON MODERNIZATION AND EXPANSION OF HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
10.4.2.1
RISE IN RESEARCH APPLICATIONS USING PROTEINS & PROTEIN CRYSTALS TO PROPEL MARKET GROWTH
10.4.3.1
INVESTMENTS AND FUNDING ACTIVITIES IN INDIAN BIOTECHNOLOGY AND BIOPHARMA INDUSTRY TO AUGMENT MARKET GROWTH
10.4.4.1
RISING INVESTMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
10.4.5.1
STRONG ACADEMIC & RESEARCH INFRASTRUCTURE AND FAVORABLE NATIONAL FUNDING PROGRAMS TO AID MARKET GROWTH
10.4.6
REST OF ASIA PACIFIC
10.5.1.1
GROWING ADOPTION OF PROTEINS IN RESEARCH CENTERS AND WORKSHOPS TO PROPEL MARKET GROWTH
10.5.2.1
INCREASING INVESTMENTS AND FUNDING FOR DEVELOPMENT AND MANUFACTURING OF PROTEIN-BASED APIS TO DRIVE MARKET
10.5.3
REST OF LATIN AMERICA
10.6
MIDDLE EAST & AFRICA
10.6.1.1
GOVERNMENT INITIATIVES FOR BETTER DIGITAL HEALTH AND IMPROVED TELEMEDICINE TO DRIVE MARKET
10.6.2
REST OF MIDDLE EAST & AFRICA
11
COMPETITIVE LANDSCAPE
Uncover strategic dominance and emerging players shaping the future of protein markets.
192
11.2
KEY PLAYER STRATEGY/RIGHT TO WIN
11.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEINS & PROTEIN CRYSTALS MARKET
11.3
REVENUE ANALYSIS, 2021–2024
11.4
MARKET SHARE ANALYSIS, 2024
11.5
COMPANY VALUATION & FINANCIAL METRICS
11.6
BRAND/PRODUCT COMPARISON
11.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.7.5.1
COMPANY FOOTPRINT
11.7.5.2
REGION FOOTPRINT
11.7.5.3
PRODUCT FOOTPRINT
11.7.5.4
APPLICATION FOOTPRINT
11.7.5.5
END-USER FOOTPRINT
11.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES (2024)
11.8.1
PROGRESSIVE COMPANIES
11.8.2
RESPONSIVE COMPANIES
11.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
11.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
11.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
11.9
COMPETITIVE SCENARIO
12
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
210
12.1.1
DANAHER CORPORATION
12.1.1.1
BUSINESS OVERVIEW
12.1.1.2
PRODUCTS OFFERED
12.1.1.3
RECENT DEVELOPMENTS
12.1.1.4.2
STRATEGIC CHOICES
12.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
12.1.5
ELI LILLY AND COMPANY
12.1.6
F. HOFFMANN-LA ROCHE LTD.
12.1.9
THERMO FISHER SCIENTIFIC INC.
12.1.11
AGILENT TECHNOLOGIES, INC.
12.1.12
TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.1.13
INTERNATIONAL FLAVOURS & FRAGRANCES INC. (IFF)
12.2.4
BIOLAXI ENZYMES PVT. LTD.
12.2.8
ASSOCIATED BRITISH FOODS PLC
12.2.10
NAGASE & CO., LTD.
12.2.15
PROTALIX BIOTHERAPEUTICS
13
RESEARCH METHODOLOGY
281
13.1.1
SECONDARY RESEARCH
13.1.1.1
KEY SECONDARY SOURCES
13.1.1.2
OBJECTIVES OF SECONDARY RESEARCH
13.1.1.3
KEY DATA FROM SECONDARY SOURCES
13.1.2.1
KEY PRIMARY SOURCES
13.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
13.1.2.3
KEY INDUSTRY INSIGHTS
13.2
MARKET SIZE ESTIMATION APPROACH
13.2.1
COMPANY REVENUE ESTIMATION APPROACH
13.2.2
CUSTOMER-BASED MARKET ESTIMATION
13.3
MARKET FORECASTING APPROACH
13.5
MARKET SHARE ASSESSMENT
13.7
RESEARCH LIMITATIONS
14.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3
CUSTOMIZATION OPTIONS
TABLE 1
PROTEINS & PROTEIN CRYSTALS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
UNMET NEEDS IN PROTEINS & PROTEIN CRYSTALS MARKET
TABLE 3
PROTEINS & PROTEIN CRYSTALS MARKET: PORTER’S FIVE FORCES
TABLE 4
AVERAGE SELLING PRICE OF PROTEINS & PROTEIN CRYSTALS, BY KEY PLAYER, 2024 (USD)
TABLE 5
AVERAGE SELLING PRICE TREND OF PROTEINS & PROTEIN CRYSTALS, BY REGION, 2022–2024 (USD)
TABLE 6
IMPORT DATA FOR HS CODE 3507, BY COUNTRY, 2021–2024 (USD THOUSAND)
TABLE 7
EXPORT DATA FOR HS CODE 3507, BY COUNTRY, 2021–2024 (USD THOUSAND)
TABLE 8
IMPORT DATA FOR HS CODE 293719, BY COUNTRY, 2021-2024 (USD THOUSAND)
TABLE 9
EXPORT DATA FOR HS CODE 293719, BY COUNTRY, 2021-2024 (USD THOUSAND)
TABLE 10
LIST OF MAJOR CONFERENCES & EVENTS IN PROTEINS & PROTEIN CRYSTALS MARKET, JANUARY 2025–DECEMBER 2026
TABLE 11
CASE STUDY: COMPUTATIONAL DESIGN OF HIGH-AFFINITY MINIBINDER PROTEINS FOR THERAPEUTIC TARGETS
TABLE 12
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 13
CASE STUDY: ALPHAFOLD BY DEEPMIND
TABLE 14
KEY REGULATORY AGENCIES
TABLE 15
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19
MIDDLE EAST: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21
INDUSTRY STANDARDS FOR PROTEINS & PROTEIN CRYSTALS MARKET
TABLE 22
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS IN PROTEINS & PROTEIN CRYSTALS MARKET (%)
TABLE 23
KEY BUYING CRITERIA FOR MAJOR END USERS IN PROTEINS & PROTEIN CRYSTALS MARKET
TABLE 24
PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 25
ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 26
ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY REGION, 2023–2030 (USD BILLION)
TABLE 27
ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET FOR INDUSTRIAL ENZYMES, BY REGION, 2023–2030 (USD BILLION)
TABLE 28
ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET FOR FOOD ENZYMES, BY REGION, 2023–2030 (USD BILLION)
TABLE 29
THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 30
THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY REGION, 2023–2030 (USD BILLION)
TABLE 31
THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2023–2030 (USD BILLION)
TABLE 32
THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET FOR INSULIN, BY REGION, 2023–2030 (USD BILLION)
TABLE 33
THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET FOR HORMONES, BY REGION, 2023–2030 (USD BILLION)
TABLE 34
THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET FOR COAGULATION FACTORS, BY REGION, 2023–2030 (USD BILLION)
TABLE 35
STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 36
STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY REGION, 2023–2030 (USD BILLION)
TABLE 37
STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET FOR RESEARCH PROTEINS, BY REGION, 2023–2030 (USD BILLION)
TABLE 38
STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET FOR STRUCTURAL PROTEINS, BY REGION, 2023–2030 (USD BILLION)
TABLE 39
SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 40
SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY REGION, 2023–2030 (USD BILLION)
TABLE 41
SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET FOR INDUSTRIAL PROTEINS, BY REGION, 2023–2030 (USD BILLION)
TABLE 42
SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET FOR NUTRITIONAL PROTEINS, BY REGION, 2023–2030 (USD BILLION)
TABLE 43
SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET FOR ANALYTICAL PROTEINS, BY REGION, 2023–2030 (USD BILLION)
TABLE 44
SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET FOR COSMECEUTICAL PROTEINS, BY REGION, 2023–2030 (USD BILLION)
TABLE 45
SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET FOR FUNCTIONAL FOOD PROTEINS, BY REGION, 2023–2030 (USD BILLION)
TABLE 46
PROTEINS & PROTEIN CRYSTALS MARKET, BY APPLICATION, 2023–2030 (USD BILLION)
TABLE 47
PROTEINS & PROTEIN CRYSTALS APPLICATIONS MARKET, BY REGION, 2023–2030 (USD BILLION)
TABLE 48
PROTEINS & PROTEIN CRYSTALS MARKET FOR HEALTHCARE, BY REGION, 2023–2030 (USD BILLION)
TABLE 49
PROTEINS & PROTEIN CRYSTALS MARKET FOR TISSUE ENGINEERING, BY REGION, 2023–2030 (USD BILLION)
TABLE 50
PROTEINS & PROTEIN CRYSTALS MARKET FOR AGRICULTURE & ANIMAL NUTRITION, BY REGION, 2023–2030 (USD BILLION)
TABLE 51
PROTEINS & PROTEIN CRYSTALS MARKET FOR INDUSTRIAL PROCESSING, BY REGION, 2023–2030 (USD BILLION)
TABLE 52
PROTEINS & PROTEIN CRYSTALS MARKET FOR BIOENERGY & ENVIRONMENTAL, BY REGION, 2023–2030 (USD BILLION)
TABLE 53
PROTEINS & PROTEIN CRYSTALS MARKET FOR COSMECEUTICAL & NUTRACEUTICALS, BY REGION, 2023–2030 (USD BILLION)
TABLE 54
PROTEINS & PROTEIN CRYSTALS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD BILLION)
TABLE 55
PROTEINS & PROTEIN CRYSTALS MARKET, BY END USER, 2023–2030 (USD BILLION)
TABLE 56
PROTEINS & PROTEIN CRYSTALS MARKET FOR PHARMA INDUSTRY, BY TYPE, 2023–2030 (USD BILLION)
TABLE 57
PROTEINS & PROTEIN CRYSTALS MARKET FOR PHARMA INDUSTRY, BY REGION, 2023–2030 (USD BILLION)
TABLE 58
PHARMA INDUSTRY MARKET FOR DRUG DEVELOPMENT, BY REGION, 2023–2030 (USD BILLION)
TABLE 59
PHARMA INDUSTRY MARKET FOR FORMULATION/MANUFACTURING, BY REGION, 2023–2030 (USD BILLION)
TABLE 60
PHARMA INDUSTRY MARKET FOR STORAGE/INVENTORY MANAGEMENT, BY REGION, 2023–2030 (USD BILLION)
TABLE 61
PROTEINS & PROTEIN CRYSTALS MARKET FOR BIOTECHNOLOGY INDUSTRY, BY TYPE, 2023–2030 (USD BILLION)
TABLE 62
PROTEINS & PROTEIN CRYSTALS MARKET FOR BIOTECHNOLOGY INDUSTRY, BY REGION, 2023–2030 (USD BILLION)
TABLE 63
BIOTECHNOLOGY INDUSTRY MARKET FOR DRUG DEVELOPMENT, BY REGION, 2023–2030 (USD BILLION)
TABLE 64
BIOTECHNOLOGY INDUSTRY MARKET FOR FORMULATION/MANUFACTURING, BY REGION, 2023–2030 (USD BILLION)
TABLE 65
BIOTECHNOLOGY INDUSTRY MARKET FOR STORAGE/INVENTORY MANAGEMNET, BY REGION, 2023–2030 (USD BILLION)
TABLE 66
PROTEINS & PROTEIN CRYSTALS MARKET FOR RESEARCH, ACADEMIA, AND CROS, BY TYPE, 2023–2030 (USD BILLION)
TABLE 67
PROTEINS & PROTEIN CRYSTALS MARKET FOR RESEARCH, ACADEMIA, AND CROS, BY REGION, 2023–2030 (USD BILLION)
TABLE 68
RESEARCH, ACADEMIA, AND CROS MARKET FOR DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2023–2030 (USD BILLION)
TABLE 69
RESEARCH, ACADEMIA, AND CROS MARKET FOR LIFE SCIENCE RESEARCH, BY REGION, 2023–2030 (USD BILLION)
TABLE 70
PROTEINS & PROTEIN CRYSTALS MARKET FOR FOOD & BEVERAGE INDUSTRY, BY REGION, 2023–2030 (USD BILLION)
TABLE 71
PROTEINS & PROTEIN CRYSTALS MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD BILLION)
TABLE 72
PROTEINS & PROTEIN CRYSTALS MARKET, BY REGION, 2023–2030 (USD BILLION)
TABLE 73
NORTH AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY COUNTRY, 2023–2030 (USD BILLION)
TABLE 74
NORTH AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 75
NORTH AMERICA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 76
NORTH AMERICA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 77
NORTH AMERICA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 78
NORTH AMERICA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 79
NORTH AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY APPLICATION, 2023–2030 (USD BILLION)
TABLE 80
NORTH AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY END USER, 2023–2030 (USD BILLION)
TABLE 81
US: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 82
US: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 83
US: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 84
US: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 85
US: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 86
CANADA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 87
CANADA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 88
CANADA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 89
CANADA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 90
CANADA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 91
EUROPE: PROTEINS & PROTEIN CRYSTALS MARKET, BY COUNTRY, 2023–2030 (USD BILLION)
TABLE 92
EUROPE: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 93
EUROPE: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE 2023–2030 (USD BILLION)
TABLE 94
EUROPE: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 95
EUROPE: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE 2023–2030 (USD BILLION)
TABLE 96
EUROPE: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 97
EUROPE: PROTEINS & PROTEIN CRYSTALS MARKET, BY APPLICATION, 2023–2030 (USD BILLION)
TABLE 98
EUROPE: PROTEINS & PROTEIN CRYSTALS MARKET, BY END USER, 2023–2030 (USD BILLION)
TABLE 99
GERMANY: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 100
GERMANY: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 101
GERMANY: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 102
GERMANY: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 103
GERMANY: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 104
UK: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 105
UK: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 106
UK: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 107
UK: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 108
UK: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 109
FRANCE: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 110
FRANCE: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 111
FRANCE: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 112
FRANCE: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 113
FRANCE: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 114
ITALY: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 115
ITALY: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 116
ITALY: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 117
ITALY: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 118
ITALY: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 119
SPAIN: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 120
SPAIN: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 121
SPAIN: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 122
SPAIN: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 123
SPAIN: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 124
REST OF EUROPE: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 125
REST OF EUROPE: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 126
REST OF EUROPE: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 127
REST OF EUROPE: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 128
REST OF EUROPE: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 129
ASIA PACIFIC: PROTEINS & PROTEIN CRYSTALS MARKET, BY COUNTRY, 2023–2030 (USD BILLION)
TABLE 130
ASIA PACIFIC: PROTEINS & PROTEIN CRYSTALS MARKET, BY COUNTRY, 2023–2030 (USD BILLION)
TABLE 131
ASIA PACIFIC: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 132
ASIA PACIFIC: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 133
ASIA PACIFIC: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 134
ASIA PACIFIC: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 135
ASIA PACIFIC: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 136
ASIA PACIFIC: PROTEINS & PROTEIN CRYSTALS MARKET, BY APPLICATION, 2023–2030 (USD BILLION)
TABLE 137
ASIA PACIFIC: PROTEINS & PROTEIN CRYSTALS MARKET, BY END USER, 2023–2030 (USD BILLION)
TABLE 138
CHINA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 139
CHINA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 140
CHINA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 141
CHINA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 142
CHINA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 143
JAPAN: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 144
JAPAN: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 145
JAPAN: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 146
JAPAN: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 147
JAPAN: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 148
INDIA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 149
INDIA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 150
INDIA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 151
INDIA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 152
INDIA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 153
AUSTRALIA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 154
AUSTRALIA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 155
AUSTRALIA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 156
AUSTRALIA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 157
AUSTRALIA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 158
SOUTH KOREA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 159
SOUTH KOREA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 160
SOUTH KOREA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 161
SOUTH KOREA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 162
SOUTH KOREA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 163
REST OF ASIA PACIFIC: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 164
REST OF ASIA PACIFIC: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 165
REST OF ASIA PACIFIC: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 166
REST OF ASIA PACIFIC: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 167
REST OF ASIA PACIFIC: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 168
LATIN AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY COUNTRY, 2023–2030 (USD BILLION)
TABLE 169
LATIN AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 170
LATIN AMERICA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 171
LATIN AMERICA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 172
LATIN AMERICA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 173
LATIN AMERICA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 174
LATIN AMERICA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY APPLICATION, 2023–2030 (USD BILLION)
TABLE 175
LATIN AMERICA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY END USER, 2023–2030 (USD BILLION)
TABLE 176
BRAZIL: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 177
BRAZIL: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 178
BRAZIL: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 179
BRAZIL: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 180
BRAZIL: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 181
MEXICO: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 182
MEXICO: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 183
MEXICO: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 184
MEXICO: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 185
MEXICO: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 186
REST OF LATIN AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 187
REST OF LATIN AMERICA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 188
REST OF LATIN AMERICA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 189
REST OF LATIN AMERICA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 190
REST OF LATIN AMERICA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 191
MIDDLE EAST & AFRICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY REGION, 2023–2030 (USD BILLION)
TABLE 192
MIDDLE EAST & AFRICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 193
MIDDLE EAST & AFRICA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 194
MIDDLE EAST & AFRICA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 195
MIDDLE EAST & AFRICA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 196
MIDDLE EAST & AFRICA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 197
MIDDLE EAST & AFRICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY APPLICATION, 2023–2030 (USD BILLION)
TABLE 198
MIDDLE EAST & AFRICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY END USER, 2023–2030 (USD BILLION)
TABLE 199
GCC COUNTRIES: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 200
GCC COUNTRIES: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 201
GCC COUNTRIES: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 202
GCC COUNTRIES: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 203
GCC COUNTRIES: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 204
REST OF MIDDLE EAST & AFRICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023–2030 (USD BILLION)
TABLE 205
REST OF MIDDLE EAST & AFRICA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 206
REST OF MIDDLE EAST & AFRICA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 207
REST OF MIDDLE EAST & AFRICA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 208
REST OF MIDDLE EAST & AFRICA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023–2030 (USD BILLION)
TABLE 209
OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN PROTEINS & PROTEIN CRYSTALS MARKET
TABLE 210
PROTEINS & PROTEIN CRYSTALS MARKET: DEGREE OF COMPETITION
TABLE 211
PROTEINS & PROTEIN CRYSTALS MARKET: REGION FOOTPRINT
TABLE 212
PROTEINS & PROTEIN CRYSTALS MARKET: PRODUCT FOOTPRINT
TABLE 213
PROTEINS & PROTEIN CRYSTALS MARKET: APPLICATION FOOTPRINT
TABLE 214
PROTEINS & PROTEIN CRYSTALS MARKET: END-USER FOOTPRINT
TABLE 215
PROTEINS & PROTEIN CRYSTALS MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
TABLE 216
PROTEINS & PROTEIN CRYSTALS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY REGION
TABLE 217
PROTEINS & PROTEIN CRYSTALS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT TYPE
TABLE 218
PROTEINS & PROTEIN CRYSTALS MARKET: PRODUCT APPROVALS, JANUARY 2022–DECEMBER 2025
TABLE 219
PROTEINS & PROTEIN CRYSTALS MARKET: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 220
PROTEINS & PROTEIN CRYSTALS MARKET: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 221
DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 222
DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 223
DANAHER CORPORATION: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 224
DANAHER CORPORATION: EXPANSIONS, JANUARY 2022–DECEMBER 2025
TABLE 225
RAYBIOTECH, INC.: COMPANY OVERVIEW
TABLE 226
RAYBIOTECH, INC.: PRODUCTS OFFERED
TABLE 227
RAYBIOTECH, INC.: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 228
MERCK & CO., INC.: COMPANY OVERVIEW
TABLE 229
MERCK & CO., INC.: PRODUCTS OFFERED
TABLE 230
MERCK & CO., INC.: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 231
AMGEN INC.: COMPANY OVERVIEW
TABLE 232
AMGEN INC.: PRODUCTS OFFERED
TABLE 233
AMGEN INC.: PRODUCT APPROVALS, JANUARY 2022–DECEMBER 2025
TABLE 234
AMGEN INC.: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 235
ELI LILLY AND COMPANY: COMPANY OVERVIEW
TABLE 236
ELI LILLY AND COMPANY: PRODUCTS OFFERED
TABLE 237
ELI LILLY AND COMPANY: PRODUCT APPROVALS, JANUARY 2022–DECEMBER 2025
TABLE 238
ELI LILLY AND COMPANY: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 239
F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 240
F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 241
F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–DECEMBER 2025
TABLE 242
F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 243
NOVO NORDISK A/S: COMPANY OVERVIEW
TABLE 244
NOVO NORDISK A/S: PRODUCTS OFFERED
TABLE 245
NOVO NORDISK A/S: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 246
PFIZER INC.: COMPANY OVERVIEW
TABLE 247
PFIZER INC.: PRODUCTS OFFERED
TABLE 248
PFIZER INC.: PRODUCT APPROVALS, JANUARY 2022–DECEMBER 2025
TABLE 249
PFIZER INC.: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 250
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 251
THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 252
SANOFI: COMPANY OVERVIEW
TABLE 253
SANOFI: PRODUCTS OFFERED
TABLE 254
AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 255
AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 256
AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 257
AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2022–DECEMBER 2025
TABLE 258
TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY OVERVIEW
TABLE 259
TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCTS OFFERED
TABLE 260
TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCT APPROVALS, JANUARY 2022–DECEMBER 2025
TABLE 261
INTERNATIONAL FLAVOURS & FRAGRANCES INC. (IFF): COMPANY OVERVIEW
TABLE 262
INTERNATIONAL FLAVOURS & FRAGRANCES INC. (IFF): PRODUCTS OFFERED
TABLE 263
INTERNATIONAL FLAVOURS & FRAGRANCES INC. (IFF): PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–DECEMBER 2025
TABLE 264
INTERNATIONAL FLAVOURS & FRAGRANCES INC. (IFF): DEALS, JANUARY 2022–DECEMBER 2025
TABLE 265
INTERNATIONAL FLAVOURS & FRAGRANCES INC. (IFF): EXPANSIONS, JANUARY 2022–DECEMBER 2025
TABLE 266
BIOCON: COMPANY OVERVIEW
TABLE 267
BIOCON: PRODUCTS OFFERED
TABLE 268
BIOCON: PRODUCT APPROVALS, JANUARY 2022–DECEMBER 2025
TABLE 269
BIOCON: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 270
AMANO ENZYME INC.: COMPANY OVERVIEW
TABLE 271
ULTREZE ENZYMES: COMPANY OVERVIEW
TABLE 272
NEOGEN: COMPANY OVERVIEW
TABLE 273
BIOLAXI ENZYMES PVT. LTD.: COMPANY OVERVIEW
TABLE 274
GENSCRIPT: COMPANY OVERVIEW
TABLE 275
BIOSEUTICA: COMPANY OVERVIEW
TABLE 276
KERRY GROUP PLC: COMPANY OVERVIEW
TABLE 277
ASSOCIATED BRITISH FOODS PLC: COMPANY OVERVIEW
TABLE 278
K-GENIX GROUP: COMPANY OVERVIEW
TABLE 279
NAGASE & CO., LTD.: COMPANY OVERVIEW
TABLE 280
GRIFOLS, S.A : COMPANY OVERVIEW
TABLE 281
BASF: COMPANY OVERVIEW
TABLE 282
BIO-CAT: COMPANY OVERVIEW
TABLE 283
AMCO PROTEINS: COMPANY OVERVIEW
TABLE 284
PROTALIX BIOTHERAPEUTICS: COMPANY OVERVIEW
TABLE 285
PROTEINS & PROTEIN CRYSTALS MARKET: STUDY ASSUMPTIONS
TABLE 286
PROTEINS & PROTEIN CRYSTALS MARKET: RISK ANALYSIS
FIGURE 1
PROTEINS & PROTEIN CRYSTALS MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
PROTEINS & PROTEIN CRYSTALS MARKET: YEARS CONSIDERED
FIGURE 3
MARKET SCENARIO FOR PROTEINS & PROTEIN CRYSTALS MARKET
FIGURE 4
GLOBAL PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT, 2024–2030 (USD BILLION)
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEINS & PROTEIN CRYSTALS MARKET, 2021–2024
FIGURE 6
DISRUPTIONS INFLUENCING GROWTH OF PROTEINS & PROTEIN CRYSTALS MARKET
FIGURE 7
HIGH-GROWTH SEGMENTS IN PROTEINS & PROTEIN CRYSTALS MARKET, 2025–2030
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 9
RAPID EXPANSION OF BIOLOGICS AND RECOMBINANT PROTEIN THERAPEUTICS TO PROPEL MARKET GROWTH
FIGURE 10
GLOBAL FORMULATIONS/END PRODUCTS, PROTEINS & PROTEIN CRYSTALS & CRYSTAALLOGRAPHY MARKET, BY PRODUCT SEGMENT, 2025-2030 (USD BILLION)
FIGURE 11
US AND PHARMA INDUSTRY COMMANDED LARGEST MARKET SHARE IN 2025
FIGURE 12
CHINA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD
FIGURE 13
PROTEINS & PROTEIN CRYSTALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14
PROTEINS & PROTEIN CRYSTALS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 15
PROTEINS & PROTEIN CRYSTALS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 16
PROTEINS & PROTEIN CRYSTALS MARKET: VALUE CHAIN ANALYSIS
FIGURE 17
PROTEINS & PROTEIN CRYSTALS MARKET: ECOSYSTEM ANALYSIS
FIGURE 18
AVERAGE SELLING PRICE OF PROTEINS & PROTEIN CRYSTALS, BY PRODUCT, 2024 (USD)
FIGURE 19
AVERAGE SELLING PRICE OF PROTEINS & PROTEIN CRYSTALS, BY REGION, 2024 (USD THOUSAND)
FIGURE 20
PROTEINS & PROTEIN CRYSTALS MARKET: IMPORT DATA FOR HS CODE 3507, 2021–2024
FIGURE 21
PROTEINS & PROTEIN CRYSTALS MARKET: EXPORT DATA FOR HS CODE 3507, 2021–2024
FIGURE 22
PROTEINS & PROTEIN CRYSTALS MARKET: IMPORT SCENARIO FOR HS CODE 293719, 2021–2024
FIGURE 23
PROTEINS & PROTEIN CRYSTALS MARKET: EXPORT SCENARIO FOR HS CODE 293719, BY COUNTRY, 2021–2024 (USD THOUSAND)
FIGURE 24
PROTEINS & PROTEIN CRYSTALS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
FIGURE 25
FUNDING AND NUMBER OF DEALS IN PROTEINS & PROTEIN CRYSTALS MARKET, 2019–2023 (USD MILLION)
FIGURE 26
NUMBER OF INVESTOR DEALS IN PROTEINS & PROTEIN CRYSTALS MARKET, BY KEY PLAYER, 2019–2023
FIGURE 27
VALUE OF INVESTOR DEALS IN PROTEINS & PROTEIN CRYSTALS MARKET, BY KEY PLAYER, 2019–2023 (USD MILLION)
FIGURE 28
PATENT ANALYSIS FOR PROTEINS & PROTEIN CRYSTALS MARKET (JANUARY 2014–NOVEMBER 2025)
FIGURE 29
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS IN PROTEINS & PROTEIN CRYSTALS MARKET
FIGURE 30
KEY BUYING CRITERIA FOR MAJOR END USERS IN PROTEINS & PROTEIN CRYSTALS MARKET
FIGURE 31
NORTH AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET SNAPSHOT
FIGURE 32
ASIA PACIFIC: PROTEINS & PROTEIN CRYSTALS MARKET SNAPSHOT
FIGURE 33
REVENUE ANALYSIS OF KEY PLAYERS IN PROTEINS & PROTEIN CRYSTALS MARKET, 2021–2024 (USD MILLION)
FIGURE 34
MARKET SHARE ANALYSIS OF KEY PLAYERS IN PROTEINS & PROTEIN CRYSTALS MARKET (2024)
FIGURE 35
RANKING OF KEY PLAYERS IN PROTEINS & PROTEIN CRYSTALS MARKET (2024)
FIGURE 36
EV/EBITDA OF KEY VENDORS
FIGURE 37
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 38
PROTEINS & PROTEIN CRYSTALS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 39
PROTEINS & PROTEIN CRYSTALS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 40
PROTEINS & PROTEIN CRYSTALS MARKET: COMPANY FOOTPRINT
FIGURE 41
PROTEINS & PROTEIN CRYSTALS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 42
DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 43
MERCK & CO., INC.: COMPANY SNAPSHOT
FIGURE 44
AMGEN INC.: COMPANY SNAPSHOT
FIGURE 45
ELI LILLY AND COMPANY: COMPANY SNAPSHOT
FIGURE 46
F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
FIGURE 47
NOVO NORDISK A/S: COMPANY SNAPSHOT
FIGURE 48
PFIZER INC.: COMPANY SNAPSHOT
FIGURE 49
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 50
SANOFI: COMPANY SNAPSHOT
FIGURE 51
AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
FIGURE 52
TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY SNAPSHOT
FIGURE 53
INTERNATIONAL FLAVOURS & FRAGRANCES INC. (IFF): COMPANY SNAPSHOT
FIGURE 54
BIOCON: COMPANY SNAPSHOT
FIGURE 55
PROTEINS & PROTEIN CRYSTALS MARKET: RESEARCH DESIGN
FIGURE 56
PROTEINS & PROTEIN CRYSTALS MARKET: KEY SECONDARY SOURCES
FIGURE 57
PROTEINS & PROTEIN CRYSTALS MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 58
PROTEINS & PROTEIN CRYSTALS MARKET: PRIMARY SOURCES (SUPPLY AND DEMAND SIDES)
FIGURE 59
PROTEINS & PROTEIN CRYSTALS MARKET: KEY INDUSTRY INSIGHTS
FIGURE 60
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 61
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
FIGURE 62
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 63
PROTEINS & PROTEIN CRYSTALS MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION
FIGURE 64
PROTEINS & PROTEIN CRYSTALS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 65
PROTEINS & PROTEIN CRYSTALS MARKET: TOP-DOWN APPROACH
FIGURE 66
GLOBAL PROTEINS & PROTEIN CRYSTALS MARKET GROWTH PROJECTIONS
FIGURE 67
PROTEINS & PROTEIN CRYSTALS MARKET: DATA TRIANGULATION METHODOLOGY
Growth opportunities and latent adjacency in Proteins & Protein Crystals Market